We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.77%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.8B
AUM Growth
-$40.1M
Cap. Flow
-$460M
Cap. Flow %
-7.92%
Top 10 Hldgs %
24.55%
Holding
197
New
37
Increased
72
Reduced
55
Closed
17

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$46.7M
2
IRTC icon
iRhythm Holdings
IRTC
+$37M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$35.8M
4
ENTG icon
Entegris
ENTG
+$21.4M
5
GLBE icon
Global E Online
GLBE
+$20.4M

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$70.1M
2
TT icon
Trane Technologies
TT
+$69.4M
3
DDOG icon
Datadog
DDOG
+$63.8M
4
ARGX icon
argenx
ARGX
+$56M
5
GTLB icon
GitLab
GTLB
+$46.9M

Sector Composition

Rank Sector Weight
1 Healthcare 40.6%
2 Technology 18.78%
3 Industrials 17.39%
4 Consumer Discretionary 9.97%
5 Financials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IEX icon
101
IDEX
IEX
$17.3B
$15.4M 0.26%
71,587
+4,580
+7% +$923K
SNDX icon
102
Syndax Pharmaceuticals
SNDX
$1.73B
$15.1M 0.26%
+786,990
New +$16.3M
PRVA icon
103
Privia Health
PRVA
$3.01B
$15M 0.26%
822,438
+746,231
+979% +$14.2M
RCKT icon
104
Rocket Pharmaceuticals
RCKT
$351M
$14.2M 0.25%
770,691
– –
CBT icon
105
Cabot Corp
CBT
$4.55B
$13.7M 0.24%
122,820
+20,273
+20% +$2.02M
CYTK icon
106
Cytokinetics
CYTK
$10.9B
$13.4M 0.23%
254,148
– –
GPI icon
107
Group 1 Automotive
GPI
$3.53B
$13.4M 0.23%
34,943
-6,145
-15% -$2.11M
KRRO icon
108
Korro Bio
KRRO
$151M
$13.1M 0.23%
391,166
-137,989
-26% -$5.81M
NDAQ icon
109
Nasdaq
NDAQ
$53.2B
$12.3M 0.21%
+168,546
New +$11.5M
NKTR icon
110
Nektar Therapeutics
NKTR
$2.41B
$12.2M 0.21%
626,667
+124,727
+25% +$2.38M
MSI icon
111
Motorola Solutions
MSI
$71.5B
$12M 0.21%
+26,633
New +$11.1M
DYN icon
112
Dyne Therapeutics
DYN
$4.8B
$11.9M 0.21%
332,277
-152,723
-31% -$6.08M
NTAP icon
113
NetApp
NTAP
$34.1B
$11.8M 0.2%
95,422
-88,834
-48% -$11.1M
OKE icon
114
Oneok
OKE
$56.1B
$11.7M 0.2%
+128,039
New +$11.1M
SLN
115
Silence Therapeutics
SLN
$549M
$11.6M 0.2%
+640,000
New +$11.9M
GXO icon
116
GXO Logistics
GXO
$5.8B
$11.5M 0.2%
221,020
+186
+0.1% +$9.43K
RLI icon
117
RLI Corp
RLI
$5.62B
$11.4M 0.2%
146,928
+21,682
+17% +$1.6M
IDYA icon
118
IDEAYA Biosciences
IDYA
$3.5B
$10.6M 0.18%
335,000
– –
PRCT icon
119
Procept Biorobotics
PRCT
$1.02B
$10.3M 0.18%
+129,000
New +$9.16M
DELL icon
120
Dell
DELL
$262B
$10.3M 0.18%
+87,041
New +$10.1M
COGT icon
121
Cogent Biosciences
COGT
$7.07B
$9.93M 0.17%
919,635
-479,357
-34% -$4.67M
SRE icon
122
Sempra
SRE
$58.6B
$9.71M 0.17%
116,084
+37,208
+47% +$2.98M
BRKR icon
123
Bruker
BRKR
$9.79B
$9.04M 0.16%
130,843
-969
-0.7% -$62.6K
LIN icon
124
Linde
LIN
$235B
$8.97M 0.15%
18,808
+5,420
+40% +$2.47M
ACAD icon
125
Acadia Pharmaceuticals
ACAD
$4.55B
$8.88M 0.15%
+577,500
New +$9.63M
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Eventide Asset Management held 197 positions worth $5.8B, down 0.69% from $5.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $460M in Q3 2024, closing 17 positions and reducing 55 holdings. Its most notable exit was Nextpower Inc, an estimated $36.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Relay Therapeutics worth $19M.

  • Eventide Asset Management's largest Q3 2024 buy was Relay Therapeutics: 2,682,083 shares worth $19M.
  • Eventide Asset Management added most to Verona Pharma in Q3 2024, an estimated $46.7M increase.
  • Eventide Asset Management's biggest Q3 2024 reduction was Transmedics, cutting an estimated $70.1M.
  • Eventide Asset Management fully exited Nextpower Inc in Q3 2024, selling an estimated $36.6M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.8B portfolio in Q3 2024.
  • Eventide Asset Management opened 37 new positions and closed 17 in Q3 2024.
  • Eventide Asset Management's portfolio value fell 0.69% quarter-over-quarter to $5.8B.

Based on Eventide Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.